The essentials

The cholesterol/HDL ratio is your total cholesterol divided by your HDL cholesterol. Lower is better: below 5 is the usual lab limit and below 3.5 to 4 is considered favorable. It is a quick summary of heart risk, but the same ratio can hide very different numbers, so read it with your LDL, non-HDL cholesterol and overall risk.

How do I read the cholesterol/HDL ratio on my lab report?

In this fictitious lipid panel, the ratio is not measured: the laboratory calculates it from two lines above it.

Fictitious example of a lab report line (United States format)
TestResultReference rangeFlag
Cholesterol, total210 mg/dL<200 mg/dLH
HDL cholesterol42 mg/dL>=40 mg/dL-
Triglycerides140 mg/dL<150 mg/dL-
LDL cholesterol, calculated140 mg/dL<100 mg/dLH
Non-HDL cholesterol168 mg/dL<130 mg/dLH
Chol/HDL ratio5.0<5.0H
  1. Total cholesterol and HDL are the two measured values behind the ratio.
  2. Chol/HDL ratio 5.0: 210 ÷ 42 = 5.0. It has no unit, and you get the same ratio from mg/dL or mmol/L values.
  3. Reference range: many labs print "less than 5.0"; others use a stricter limit, such as below 4[9]. Your laboratory's range prevails.
  4. Non-HDL cholesterol: the same two numbers subtracted instead of divided (210 − 42 = 168).

Same total cholesterol, different story: with an HDL of 70 mg/dL, the ratio would be 3.0. Our guide to reading a lipid panel explains each of the other lines.

A ratio is only one line of your report. BloodSense reads your complete lipid panel line by line and helps you prepare your questions for the visit.

Get my cholesterol results explained

What is the cholesterol/HDL ratio used for?

The ratio puts two opposite forces into one number. Total cholesterol includes the particles that build plaque in artery walls, while HDL cholesterol is linked with lower risk. Dividing one by the other shows the balance between them. It is sometimes called the Castelli index[3].

It is a strong summary. In 61 studies with about 900,000 adults, the total/HDL ratio was the best simple predictor of death from coronary heart disease: 40% more informative than non-HDL cholesterol and more than twice as informative as total cholesterol alone[2].

That is why some risk calculators use it. QRISK3, the tool used by family doctors in England, takes the total cholesterol/HDL ratio as an input[6]. The American Heart Association's PREVENT equations, by contrast, use non-HDL and HDL cholesterol separately[7]. Either way, the ratio feeds a risk estimate; it is not a diagnosis.

What is a good cholesterol/HDL ratio?

Lower is better. Cut-offs vary between sources and laboratories, and are often stricter for women, whose HDL limits are higher[1].

Examples of cut-offs for the total cholesterol/HDL ratio in adults (your laboratory's range prevails)
SituationMenWomenSource
Higher risk, no heart diseaseAbove 5.0Above 4.5Spanish lipid experts' review[3]
Target, no heart diseaseBelow 4.5Below 4.0Same review[3]
Target after a heart attack or strokeBelow 3.5Below 3.0Same review[3]
Example of a hospital lab rangeBelow 4Dutch hospital laboratory guide[9]

The ratio has no unit, so these figures apply whether your lab reports cholesterol in mg/dL or mmol/L. For the individual values, MedlinePlus gives a healthy total cholesterol below 200 mg/dL and an HDL of 60 mg/dL or more as best, with HDL below 40 mg/dL (men) or 50 mg/dL (women) considered low[1].

What does a high cholesterol/HDL ratio mean?

A high ratio means too much cholesterol in plaque-forming particles, too little HDL, or both. It raises the odds of heart disease but causes no symptoms.

  • Common Low HDL with inactivity, smoking, excess belly weight, high triglycerides or insulin resistance. Low HDL travels with the features of metabolic syndrome[3].
  • Common High LDL cholesterol, from diet, weight or family tendency, which pushes total cholesterol up. See LDL cholesterol levels.
  • Possible Another condition that raises cholesterol, such as an underactive thyroid, or certain medicines. Pregnancy raises total cholesterol by about 40% in the second and third trimesters, so a ratio then says little about heart risk[9].
  • Rare Inherited high cholesterol (familial hypercholesterolemia), suspected when LDL is above about 190 mg/dL[10].

A low ratio is usually reassuring. But it can come from a very high HDL, and a high HDL does not cancel a high LDL. The opposite trap also exists: a ratio can look fine while every value is high.

Two people with the same ratio of 4.0
PersonTotal cholesterolHDLRatioNon-HDL
A300 mg/dL75 mg/dL4.0225 mg/dL
B160 mg/dL40 mg/dL4.0120 mg/dL

Person A carries almost twice as much cholesterol in harmful particles. This is why doctors never treat the ratio alone.

Cholesterol ratio, non-HDL, LDL or ApoB/ApoA1: which matters most?

How the ratio compares with other lipid measures
MeasureHow it is obtainedMain use
Total/HDL ratioTotal cholesterol ÷ HDLRisk summary; input for QRISK3[6]
Non-HDL cholesterolTotal cholesterol − HDLRisk estimate in PREVENT; no fasting needed[7]
LDL cholesterolUsually calculated by a formulaMain treatment goal in guidelines[11]
ApoB/ApoA1 ratioTwo extra protein testsCounts particles rather than cholesterol[4]

The ratio and non-HDL come from the same two numbers. In 302,430 people, the non-HDL/HDL ratio and the ApoB/ApoA1 ratio predicted heart disease about equally well (hazard ratios 1.50 and 1.49)[5]. In the INTERHEART study across 52 countries, the ApoB/ApoA1 ratio did better: it accounted for 54% of the population risk of heart attack, against 32% for the total/HDL ratio[4]. Apolipoproteins cost an extra test, so they are usually reserved for unclear cases: see apolipoprotein B and apolipoprotein A1.

When it comes to treatment, your doctor will talk mainly about LDL. The 2026 US guideline, for example, sets an LDL goal below 55 mg/dL for patients at very high risk[11].

What can affect the ratio before the blood test?

  • Fasting matters little: after a usual meal, total cholesterol falls by about 8 mg/dL at most and HDL does not change[10]. Follow your doctor's instructions anyway; see fasting before a blood test.
  • Wait at least 3 months after a heart attack or a serious infection: cholesterol can be falsely low[9].
  • Avoid testing during pregnancy for a heart-risk check[9].
  • Compare ratios from the same laboratory, and allow about 3 months after changing diet, weight or medicine.
  • Keep taking your usual medicines unless told otherwise.

When should I see a doctor about my cholesterol ratio?

When to see a doctor

  • Emergency: call 911 for chest pain, sudden breathlessness, one-sided weakness, trouble speaking or a drooping face.
  • Within a few weeks if LDL is above 190 mg/dL or triglycerides are above 880 mg/dL, or if close relatives had heart disease young[10].
  • At your next appointment for a ratio flagged high, or one that rises between two tests.

Questions to ask your doctor

  1. Is my ratio high because of my LDL, my HDL or both?
  2. What is my overall 10-year heart risk, and which numbers went into it?
  3. Should I aim for an LDL or non-HDL goal, and which one?
  4. Would an apoB or Lp(a) test change anything for me?

Frequently asked questions

Is a cholesterol ratio of 3 good?

Yes, a ratio of 3 is below the cut-offs used for men and women without heart disease[3]. Still check your LDL: a very high HDL can lower the ratio without lowering LDL.

Can I calculate my cholesterol ratio myself?

Yes: divide total cholesterol by HDL, both in the same unit. A total of 200 with an HDL of 50 gives 4.0.

Is the cholesterol/HDL ratio the same as the LDL/HDL ratio?

No. The LDL/HDL ratio uses LDL instead of total cholesterol, so its cut-offs are lower, around 3 to 3.5 for men in primary prevention[3].

Does a statin change the ratio?

Usually yes, because it lowers total cholesterol much more than it changes HDL. Your doctor will judge the effect mainly on LDL or non-HDL cholesterol.

  1. MedlinePlus. Cholesterol levels. US National Library of Medicine. medlineplus.gov (accessed November 1, 2026)
  2. Prospective Studies Collaboration; Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829-1839. doi:10.1016/S0140-6736(07)61778-4 (accessed November 1, 2026)
  3. Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757-765. doi:10.2147/VHRM.S6269 (accessed November 1, 2026)
  4. McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008;372(9634):224-233. doi:10.1016/S0140-6736(08)61076-4 (accessed November 1, 2026)
  5. Emerging Risk Factors Collaboration; Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993-2000. doi:10.1001/jama.2009.1619 (accessed November 1, 2026)
  6. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. doi:10.1136/bmj.j2099 (accessed November 1, 2026)
  7. Khan SS, Matsushita K, Sang Y, et al. Development and validation of the American Heart Association's PREVENT equations. Circulation. 2024;149(6):430-449. doi:10.1161/CIRCULATIONAHA.123.067626 (accessed November 1, 2026)
  8. Centers for Disease Control and Prevention. Testing for cholesterol. Reviewed May 15, 2024. cdc.gov (accessed November 1, 2026)
  9. Slingeland Ziekenhuis. Cholesterol/HDL ratio (K-CHOL_HDL). Laboratory test guide. slingeland.nl (accessed November 1, 2026)
  10. Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-1958. doi:10.1093/eurheartj/ehw152 (accessed November 1, 2026)
  11. Siddiqi AK, Jacob J, Khan MS, Kulkarni A. Top 10 concepts in secondary ASCVD prevention from the 2026 ACC/AHA dyslipidemia guideline: what is new and why it matters. Curr Atheroscler Rep. 2026;28(1). doi:10.1007/s11883-026-01465-5 (accessed November 1, 2026)
  12. Medicare.gov. Cardiovascular disease screenings. Centers for Medicare & Medicaid Services. medicare.gov (accessed November 1, 2026)

This page is general information. It does not replace the advice of a doctor, who interprets your results with your symptoms, history and examination.